You searched for metabolic diseases - Page 46 of 62

News and Trends 4 Nov 2022

EMPA-KIDNEY trial meets primary endpoint in trial for drug to treat chronic kidney disease

…spectrum of cardiovascular, kidney or metabolic conditions. The trial assessed both kidney and cardiovascular outcomes in people across the spectrum of CKD severity. “The Boehringer Ingelheim and Lilly Alliance is incredibly proud…

November 4, 2022 - 4 minutesmins - By Liza Laws

Scenic biotech lysosomal storage disorders

News and Trends 10 Mar 2022

Emerging Startups Take Aim at Lysosomal Storage Disorders

…to treat these conditions by activating protective genes. Lysosomal storage disorders are inherited conditions caused by mutations in metabolic enzymes found inside our cells, leading to the buildup of toxic…

March 10, 2022 - 4 minutesmins - By Jonathan Smith

Expert Advice 6 Feb 2020

Why a Big Pharma Background Can Give Biotech Leaders an Edge

…disease, but will die of cardiovascular diseases. Most patients have metabolic syndrome and are at high risk for cardiovascular disease. Besides that, you also see more activity around triglyceride-lowering treatments…

February 6, 2020 - 11 minutesmins - By Helen Albert

Best in Biotech 12 Jun 2023

Six advancements in Alzheimer’s research over the past year

…not interfere with other cyclin-dependent kinases – enzymes that regulate the cell cycle. As P25 has been linked to multiple neurodegenerative diseases, this could be a therapeutic breakthrough for conditions…

June 12, 2023 - 12 minutesmins - By Roohi Mariam Peter

News and Trends 11 Aug 2022

First patient enrolled on Panbela’s trial for treatment of pancreatic cancer

…with programs ranging from pre-clinical to registration studies. SBP-101 is a proprietary polyamine analogue designed to induce polyamine metabolic inhibition by exploiting an observed high affinity of the compound for…

August 11, 2022 - 3 minutesmins - By Liza Laws

young researchers entrepreneurs biotech europe 1

Best in Biotech 4 Apr 2017

Top Young Researchers Making Names for Themselves in Industry

…with an industrial yeast strain through metabolic engineering. Anastasia Krivoruchko After finishing her PhD at Carleton University, Canada, Anastasia Krivoruchko went on to do a postdoc at Chalmers University of…

April 4, 2017 - 4 minutesmins - By Denise Neves Gameiro

Best in Biotech 3 Oct 2023

Five impactful biotech companies to know in New York

…targeting diseases such as depression, Alzheimer’s disease agitation, migraine, narcolepsy, and fibromyalgia. In Just last year, the U.S. Food and Drug Administration (FDA) approved Axsome’s drug Auvelity (dextromethorphan HBr -bupropion…

October 3, 2023 - 8 minutesmins - By Willow Shah-Neville

In Depth 1 Aug 2022

The biggest US biotech investments in July 2022

The asthma specialist Areteia Therapeutics took the U.S.’ top private biotech investment crown in July 2022, with runners-up including liquid biopsy firm Delfi Diagnostics and the metabolic disease drug developer…

August 1, 2022 - 3 minutesmins - By Jonathan Smith

Sitryx immunometabolism cancer inflammation

News and Trends 8 Oct 2018

Oxford Biotech Launches with €26M to Target ‘Immunometabolism’

…growth through targeting metabolic pathways has the potential to deliver new approaches to treat a wide range of severe diseases, particularly in the areas of immuno-oncology and immuno-inflammation.” The…

October 8, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 8 Dec 2022

Laevoroc Oncology pushes for relapsed leukemia cure

…into the immunoregulatory functions of purine nucleoside phosphorylase (PNP) with Laevoroc’s PNP inhibitor, LR 09. The research shows that PNP is a novel metabolic immune checkpoint and LR 09 (Ulodesine),…

December 8, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 8 Aug 2022

Epigenic Therapeutics raises $20M for gene editing technology

…metabolic, and rare disease models. About Epigenic Therapeutics Epigenic Therapeutics is dedicated to developing next generation gene editing therapy utilizing regulation of the epigenetic genome for a variety of diseases….

August 8, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 8 Dec 2022

MetrioPharm reveals COVID-19 study data

MetrioPharm AG, a Swiss pharmaceutical company developing drugs for inflammatory diseases, has announced topline data from its CT05 phase IIa study of small molecule macrophage metabolic modulator MP1032 in COVID-19…

December 8, 2022 - 4 minutesmins - By Jim Cornall

Knowledge hub

Categories

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Approaches

Therapeutic areas

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: metabolic diseases

EMPA-KIDNEY trial meets primary endpoint in trial for drug to treat chronic kidney disease

Emerging Startups Take Aim at Lysosomal Storage Disorders

Why a Big Pharma Background Can Give Biotech Leaders an Edge

Six advancements in Alzheimer’s research over the past year

First patient enrolled on Panbela’s trial for treatment of pancreatic cancer

Top Young Researchers Making Names for Themselves in Industry

Five impactful biotech companies to know in New York

The biggest US biotech investments in July 2022

Oxford Biotech Launches with €26M to Target ‘Immunometabolism’

Laevoroc Oncology pushes for relapsed leukemia cure

Epigenic Therapeutics raises $20M for gene editing technology

MetrioPharm reveals COVID-19 study data

Subscribe to our newsletter to get the latest biotech news!

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!